BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22383632)

  • 21. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
    Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for Biocompatible Peritoneal Dialysis Solutions.
    Nataatmadja M; Cho Y; Johnson DW
    Contrib Nephrol; 2017; 189():91-101. PubMed ID: 27951555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of bicarbonate/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells.
    Fernández-Perpén A; Pérez-Lozano ML; Bajo MA; Albar-Vizcaino P; Sandoval Correa P; del Peso G; Castro MJ; Aguilera A; Ossorio M; Peter ME; Passlick-Deetjen J; Aroeira LS; Selgas R; López-Cabrera M; Sánchez-Tomero JA
    Perit Dial Int; 2012; 32(3):292-304. PubMed ID: 22215656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal dialysis solutions low in glucose degradation products--evidence for clinical benefits.
    Tomo T
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S123-7. PubMed ID: 18552241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do low GDP neutral pH solutions prevent or retard peritoneal membrane alterations in long-term peritoneal dialysis?
    Parikova A; Michalickova K; van Diepen AT; Voska L; Viklicky O; Krediet RT
    Perit Dial Int; 2022 May; 42(3):236-245. PubMed ID: 34259088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
    Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?
    Parikova A; Struijk DG; Zweers MM; Langedijk M; Schouten N; van den Berg N; Duis S; Krediet RT
    Perit Dial Int; 2007; 27(6):691-6. PubMed ID: 17984433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function.
    Alscher DM; Pauli-Magnus C; Kirchgessner J; Kuhlmann U; Mettang T
    Nephron; 2000 Sep; 86(1):62-9. PubMed ID: 10971155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
    Ha H; Cha MK; Choi HN; Lee HB
    Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid.
    Grossin N; Wautier MP; Wautier JL; Gane P; Taamma R; Boulanger E
    Perit Dial Int; 2006; 26(6):664-70. PubMed ID: 17047233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children.
    Fischbach M; Terzic J; Chauvé S; Laugel V; Muller A; Haraldsson B
    Nephrol Dial Transplant; 2004 Apr; 19(4):925-32. PubMed ID: 15031351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.
    Lee HY; Choi HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Kim MJ; Shin SK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2893-9. PubMed ID: 16957012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.